(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-dideoxy-3-(dimethylamino)-β-d-glucopyranosyl]oxy]-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-10-[[2,3,4,6-tetradeoxy-4-(dimethylamino)-β-d-erythro-hexopyranosyl]oxy]oxacyclohexadeca-11,13-dien-4-yl propanoatate (neospiramycin III); Neospiramycin III
Spiramycin EP Impurity H (Neospiramycin III) is a fully characterized chemical compound used as a reference standard of API Spiramycin. The standard offered is compliant with regulatory guidelines. Spiramycin EP Impurity H (Neospiramycin III) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 4617-99-6
